Breakthrough infections with SARS-CoV-2 omicron efficiently boost antibodies from previous BNT162b2 vaccinations

Objective: To investigate whether SARS-CoV-2 omicron breakthrough infection in individuals after three doses of wildtype-based BNT162b2 increases antibody levels measured by a commercially available wildtype-based immunoassay. Methods: 16 of 21 individuals in a BNT162b2 vaccination cohort (recruited...

Descrición completa

Detalles Bibliográficos

Principais autores:	Thomas Perkmann, David N. Springer, Patrick Mucher, Michael Wolzt, Lukas Weseslindtner, Helmuth Haslacher
Formato:	Artigo
Idioma:	Inglês
Publicado:	Elsevier 2023-08-01
Series:	Journal of Clinical Virology Plus
Assuntos:	SARS-CoV-2 Vaccination Breakthrough infection Booster Omicron
Acceso en liña:	http://www.sciencedirect.com/science/article/pii/S2667038023000248
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!